Ðǿմ«Ã½

    Advertisement
    Dibesity02:07Eli Lilly Obesity Pharma
    Ars Technica12:18Eli Lilly Obesity Pharma
    Georgia Public Broadcasting12:48Georgia Schools Ozempic Georgia
    pharmaphorum04:30Obesity The Lancet England
    News-Medical.Net06:16Obesity FDA Ozempic
    Psychiatry Advisor11:32Obesity FDA Ozempic
    The Motley Fool20:18Novo Nordisk Ozempic Obesity
    Medical Daily23:04Ozempic Obesity Mounjaro
    To Vima21:04Ozempic Obesity Mounjaro
    Gastroenterology Advisor12:06
    Renal and Urology News10:04
    CBC.ca12:37Mounjaro Obesity Canada
    battlefordsNOW08:29Mounjaro Obesity Canada
    Yesterday
    Barchart14:23 26-Jun-26
    European Medicines Agency09:38 26-Jun-26
    Men's Health09:14 26-Jun-26
    News-Medical.Net06:16 26-Jun-26
    pharmaphorum04:30 26-Jun-26
    In the last 7 days
    Medpage Today14:51 25-Jun-26
    Boston Globe12:27 25-Jun-26
    MailOnline11:03 25-Jun-26
    Tyla08:41 25-Jun-26
    LADbible08:32 25-Jun-26
    The i Paper07:20 25-Jun-26
    PR Newswire (Press Release)06:46 25-Jun-26
    Scientific American06:44 25-Jun-26
    Pharmaceutical Technology04:54 25-Jun-26
    pharmaphorum04:36 25-Jun-26
    film-news.co.uk02:09 25-Jun-26
    Medical Daily23:59 24-Jun-26
    PR Newswire (Press Release)16:20 24-Jun-26
    CBC.ca12:37 24-Jun-26
    Medpage Today12:24 24-Jun-26
    MailOnline10:18 24-Jun-26
    Clinical Trials Arena09:55 24-Jun-26
    Proactive Investors (UK)09:14 24-Jun-26
    battlefordsNOW08:29 24-Jun-26
    Pulse07:49 24-Jun-26
    PR Newswire (Press Release)07:09 24-Jun-26
    Dibesity02:07 24-Jun-26
    NewsMax19:22 23-Jun-26
    Futurism18:36 23-Jun-26
    New York Magazine17:32 23-Jun-26
    Gizmodo16:25 23-Jun-26
    Medpage Today16:03 23-Jun-26
    Daily Kos14:50 23-Jun-26
    U.S. Department of Justice (Press Release)14:42 23-Jun-26
    Psychology Today12:48 23-Jun-26
    Ars Technica12:18 23-Jun-26
    Psychiatry Advisor11:32 23-Jun-26
    Psychology Today10:04 23-Jun-26
    RTT News07:37 23-Jun-26
    PR Newswire (Press Release)06:13 23-Jun-26
    Los Angeles Times06:10 23-Jun-26
    The Motley Fool02:55 23-Jun-26
    Drugs Discovery Online00:05 23-Jun-26
    Medical Daily23:13 22-Jun-26
    Medical Daily23:04 22-Jun-26
    To Vima21:04 22-Jun-26
    Korea Biomedical Review20:30 22-Jun-26
    The Motley Fool20:18 22-Jun-26
    BNN Bloomberg17:15 22-Jun-26
    Gastroenterology Advisor13:20 22-Jun-26
    Georgia Public Broadcasting12:48 22-Jun-26
    Renal and Urology News10:17 22-Jun-26
    Heavy.com06:27 22-Jun-26
    SheThePeople03:01 22-Jun-26
    The Times of India19:03 21-Jun-26
    Newswise (Press Release)09:03 21-Jun-26
    Fortune07:14 21-Jun-26
    Hoodline20:34 20-Jun-26
    CBC.ca04:09 20-Jun-26
    The Motley Fool03:30 20-Jun-26
    In the last month
    Medical Daily08:53 19-Jun-26
    National Law Review20:02 18-Jun-26
    Gastroenterology Advisor11:43 18-Jun-26
    Zacks11:11 18-Jun-26
    Men's Health10:56 18-Jun-26
    Knowridge Science Report07:32 18-Jun-26
    Knowridge Science Report07:02 18-Jun-26
    The Nittany Turkey (Weblog)18:46 17-Jun-26
    Northwestern Now16:53 17-Jun-26
    Medical Daily10:46 17-Jun-26
    Gastroenterology Advisor10:02 17-Jun-26
    News-Medical.Net09:31 17-Jun-26
    Fox News08:01 17-Jun-26
    Knowridge Science Report07:05 17-Jun-26
    Medpage Today17:14 16-Jun-26
    Bloomberg Law16:37 16-Jun-26
    The Nittany Turkey (Weblog)16:02 16-Jun-26
    JD Supra14:29 16-Jun-26
    News-Medical.Net12:50 16-Jun-26
    News-Medical.Net12:09 16-Jun-26
    Gastroenterology Advisor12:06 16-Jun-26
    Newswise (Press Release)10:15 16-Jun-26
    Renal and Urology News10:04 16-Jun-26
    News-Medical.Net08:15 16-Jun-26
    Knowridge Science Report06:38 16-Jun-26
    The Independent01:07 16-Jun-26
    Medical Daily21:30 15-Jun-26
    Nautilus18:22 15-Jun-26
    Newswise (Press Release)17:01 15-Jun-26
    Endocrinology Advisor16:07 15-Jun-26
    Endocrinology Advisor16:07 15-Jun-26
    Newswise (Press Release)15:03 15-Jun-26
    Newswise (Press Release)15:03 15-Jun-26
    Medpage Today14:04 15-Jun-26
    Clinical Pain Advisor11:55 15-Jun-26
    HealthDay11:48 15-Jun-26
    Zacks11:48 15-Jun-26
    Newswise (Press Release)09:51 15-Jun-26
    NewsMax08:14 15-Jun-26
    Patient.info08:09 15-Jun-26
    Wellbeing News04:29 15-Jun-26
    News-Medical.Net12:49 14-Jun-26
    News-Medical.Net10:37 14-Jun-26
    News-Medical.Net10:27 14-Jun-26
    Newswise (Press Release)10:04 14-Jun-26
    Wales Online07:20 14-Jun-26
    MailOnline20:44 13-Jun-26
    Newswise (Press Release)10:40 13-Jun-26
    Gizmodo10:36 13-Jun-26
    Daily Star08:58 13-Jun-26
    Gastroenterology Advisor17:22 12-Jun-26
    The Straits Times17:04 12-Jun-26
    Medical Daily14:17 12-Jun-26
    Yale Medicine12:31 12-Jun-26
    The Motley Fool12:13 12-Jun-26
    view more headlines
    26 Jun 14:23

    About our Tirzepatide news

    Latest news on Tirzepatide, a drug that is being developed as a potential treatment for obesity and type 2 diabetes. It is a synthetic hormone that is designed to mimic the effects of natural hormones called incretins, which help to lower blood sugar and reduce appetite. Tirzepatide has shown promise in clinical trials, producing significant weight loss in people with obesity or type 2 diabetes. It is administered as a once-weekly injection, and it is believed to work by increasing the production of a hormone called GLP-1, which helps to regulate appetite and insulin production. Tirzepatide is currently in late-stage clinical trials, and it is expected to be considered for regulatory approval in the coming years.


    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.